Why Is Prucalopride (Motegrity) So Hard to Find? [Explained for 2026]

If you've ever stood at a pharmacy counter only to be told that prucalopride (brand name Motegrity) is out of stock, you're not alone. Patients across the country regularly report difficulty filling this prescription — even though it's not officially listed on the FDA's drug shortage database. So what's actually going on?

This article breaks down the real reasons prucalopride can be hard to find in 2026, what the availability landscape looks like now that a generic is on the market, and what you can do today to get your prescription filled.

Is Prucalopride Actually in Shortage?

Prucalopride is not currently on the FDA's official drug shortage list. However, "not in shortage" doesn't mean it's sitting on every pharmacy shelf. There are several structural reasons why patients frequently can't find it — reasons that have nothing to do with a formal manufacturing crisis.

Until January 2025, Motegrity was only available as a brand-name drug manufactured by Takeda Pharmaceuticals. Pharmacies often stock brand-name drugs with low demand at lower quantities, and a sudden spike in prescriptions — or a supply chain hiccup — can quickly lead to "out of stock" notices.

How Did the Generic Launch Change Things?

In January 2025, ANI Pharmaceuticals received FDA approval for the first generic version of prucalopride with 180-day exclusivity. This was a major milestone for patients who had been paying $600 or more per month for the brand-name version. Generic prucalopride is now available at many pharmacies, and with GoodRx coupons, patients can pay as little as $26–$40 for a 30-day supply — a dramatic reduction from the brand price of $550–$735.

However, the transition from brand to generic is rarely seamless. Pharmacies need to stock new generic inventory, update their systems, and some patients may still have outstanding prescriptions written for brand-name Motegrity specifically. During this transition period, availability can be inconsistent depending on which pharmacy you go to.

Why Do Some Pharmacies Have It and Others Don't?

Pharmacy inventory is driven by local demand and purchasing agreements with wholesalers. A CVS in one zip code might have plenty of generic prucalopride, while a Walgreens five miles away has none. This is especially true for:

• Smaller independent pharmacies that stock limited quantities of specialty GI drugs
• Rural areas with fewer pharmacies overall
• Chain pharmacies that recently ran out and are awaiting their next wholesaler delivery
• Pharmacies that primarily stock the brand (Motegrity) and haven't switched to the generic yet

This patchwork availability is frustrating but solvable — if you know how to search.

Insurance Barriers That Look Like Shortage

Many patients mistake insurance coverage denials for a drug shortage. Prucalopride (especially the brand-name Motegrity) is classified as a non-preferred or Tier 3–4 drug on many insurance formularies. Insurers often require step therapy — meaning you must first try and fail linaclotide (Linzess) or plecanatide (Trulance) before they'll cover prucalopride. Prior authorization is also commonly required.

If your pharmacy is telling you the drug isn't covered or the claim is rejected, that's a different problem than the drug being out of stock — but it can feel the same way when you leave empty-handed. Working with your doctor on a prior authorization request or exploring the generic as an alternative can help break through this barrier.

What About Medicare Patients?

Medicare does not cover Motegrity (prucalopride) in most Part D plans. This is a common frustration for older patients on fixed incomes who find themselves paying out of pocket for a drug that can cost over $600 per month at the brand price. The arrival of the generic in 2025 has helped significantly, but patients still need to know which pharmacies carry the generic and at what price.

How to Find Prucalopride in Stock Near You

The most reliable approach is to call pharmacies directly and ask whether they currently have prucalopride (generic) or Motegrity (brand) in stock in the dose your doctor prescribed. But this can take hours of phone calls — especially if you need to reach multiple pharmacies.

medfinder does this work for you. You tell us your medication, dose, and location, and we call pharmacies near you to find out which ones can actually fill your prescription. Results are texted directly to you — no more wasted trips or hour-long hold times.

What Else Can You Do While You Wait?

If you're unable to fill your prucalopride prescription right now, consider these options while you search:

• Ask about alternatives: Linaclotide, lubiprostone, and plecanatide are all FDA-approved for chronic idiopathic constipation and may be easier to find in stock.
• Try mail-order pharmacy: Mail-order pharmacies often have more consistent stock of specialty GI medications.
• Contact your prescriber: They may be able to help with samples, alternative prescriptions, or prior authorization to unlock coverage.

For a step-by-step guide to finding prucalopride near you, see our post: How to Find Prucalopride In Stock Near You (Tools + Tips)

The Bottom Line

Prucalopride isn't technically in shortage, but that doesn't mean it's easy to find. Brand-to-generic transition, inconsistent pharmacy stocking, insurance barriers, and limited rural availability all contribute to the frustration patients experience. The good news: the generic is now available, prices have dropped dramatically, and with the right tools, you can find it near you without the runaround.